Antioxidants stimulate BACH1-dependent tumor angiogenesis
Lung cancer progression relies on angiogenesis, which is a response to hypoxia typically coordinated by hypoxia-inducible transcription factors (HIFs), but growing evidence indicates that transcriptional programs beyond HIFs control tumor angiogenesis. Here, we show that the redox-sensitive transcri...
Main Authors: | Ting Wang, Yongqiang Dong, Zhiqiang Huang, Guoqing Zhang, Ying Zhao, Haidong Yao, Jianjiang Hu, Elin Tüksammel, Huan Cai, Ning Liang, Xiufeng Xu, Xijie Yang, Sarah Schmidt, Xi Qiao, Susanne Schlisio, Staffan Strömblad, Hong Qian, Changtao Jiang, Eckardt Treuter, Martin O. Bergo |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-10-01
|
Series: | The Journal of Clinical Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1172/JCI169671 |
Similar Items
-
BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial–mesenchymal transition and angiogenesis
by: Yan Zhao, et al.
Published: (2021-05-01) -
Angiogenesis and the Models to Study Angiogenesis
by: Ali Mostafaie, et al.
Published: (2010-01-01) -
Piperlongumine alleviates corneal allograft rejection via suppressing angiogenesis and inflammation
by: Xiangyu Fan, et al.
Published: (2022-12-01) -
Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer
by: Yingying Li, et al.
Published: (2022-03-01) -
rESWT promoted angiogenesis via Bach1/Wnt/β-catenin signaling pathway
by: Fan Yang, et al.
Published: (2024-05-01)